Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when COMPASS Pathways plc publishes a filing, an earnings call transcript or a press release.

Get CMPS alerts

About Justin Gover

Justin Gover is recorded as Board Member at COMPASS Pathways plc (CMPS) and Board Member at Design Therapeutics, Inc. (DSGN) since January 1, 2025. The newest filing on record that lists Justin Gover as Board Member at COMPASS Pathways plc (CMPS) is dated April 15, 2026. The newest filing on record that lists Justin Gover as Board Member at Design Therapeutics, Inc. (DSGN) is dated April 23, 2026. Design Therapeutics, Inc. reported in an 8-K filed September 10, 2025 that Justin Gover was appointed Class III director, effective September 9, 2025. Design Therapeutics, Inc. reported in an 8-K filed September 10, 2025 that Justin Gover was appointed chair of the Compensation Committee of the Board, effective September 9, 2025. COMPASS Pathways plc reported in an 8-K filed July 29, 2025 that Justin Gover was appointed Class III director, effective July 29, 2025. COMPASS Pathways plc is classified in the Medical Care Facilities industry within the Healthcare sector. Design Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at COMPASS Pathways plc includes Kabir Nath (CEO and Board Member), David Norton (Chairman and Board Member), George Goldsmith (Chairman) and 7 others.

“On September 9, 2025, the Board appointed Justin Gover as a member of the Board as a Class III director, effective as of the Effective Date, with a term ending at the Company's 2027 annual meeting of stockholders.”
Design Therapeutics, Inc. Form 8-K, filed September 10, 2025 · Read the filing
“Mr. Gover was also appointed as chair of the Compensation Committee of the Board (the "Compensation Committee").”
Design Therapeutics, Inc. Form 8-K, filed September 10, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at COMPASS Pathways plc

Leadership on record at Design Therapeutics, Inc.

Recent activity